NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

遠端患者監護系統的全球市場

Remote Patient Monitoring Systems

出版商 Global Industry Analysts, Inc. 商品編碼 339777
出版日期 內容資訊 英文 269 Pages
商品交期: 最快1-2個工作天內
價格
遠端患者監護系統的全球市場 Remote Patient Monitoring Systems
出版日期: 2021年04月01日內容資訊: 英文 269 Pages
簡介

本報告提供遠端患者監護系統的全球市場,提供您美國,加拿大,日本,歐洲,亞太地區,南美,及其他地區等各個地區之個別分析,從2014年到2020年各年的實際成果/推估及預測,再彙整主要83家企業及利基企業公司簡介。

第1章 簡介,調查方法,產品定義

  • 調查的可靠性和報告的限制
  • 免責聲明
  • 資料的解釋和報告作成層級
    • 定量技術及分析法
  • 產品的定義和調查範圍

第2章 摘要整理

  • 產業概要
    • 遠端患者監護 (RPM) :醫療提供的變革模式
    • 對患者,醫生及費用負擔者而言的恩惠
    • 提高患者的治療結果和推動自我護理
    • 資源的最佳化節減:主要的恩惠
    • 費用負擔者的恩惠
    • 主要的推動市場成長要素的概況
    • 在全球性醫療費上升中,醫療經濟的關注度大增
    • 高齡人口產生高度需求
    • 慢性疾病管理顯示出巨大的市場機會
    • 對醫院的再住院懲罰條例提供了轉換到RPM的契機
    • 穿戴式設備促進RPM的引進
    • 創業投資家積極對RPM技術企業提供資金
    • 市場上問題與課題
    • 遠端患者監護系統的高成本
    • 缺乏給付
    • 患者的隱私相關疑慮
    • 小規模的診療所受到遠程監控計劃的挑戰
    • 醫療設備的安全性問題
    • 競爭情形
  • 市場趨勢/課題
    • 巨量資料的管理對有效RPM而言相當重要
    • 物聯網 (IoT) :對醫療而言重要
    • 雲端運算:強化RPM的引進
    • 夥伴關係活用互相的專門技術
    • 行動醫療是否會造成傳統RPM陳腐化?
    • 無線消費者設備比遠程醫療較受喜愛
    • 不能動的患者有利於遠程監控設備的引進增加
    • CVD依然在遠程監控中持續熱門
    • 遠程監控:對CIED患者而言的治療新標準
    • RPM削減了糖尿病管理相關成本
    • 神經退化性疾病症狀的遠程監控
    • EEG及治療合理的遠程監控
    • 對慢性阻塞性肺病及氣喘的管理而言重要的遠程監控
    • 遠隔血壓監測的重要性擴大有利於市場上引進
    • 睡眠呼吸中止症的遠端患者監護
  • 產品概要
    • 簡介
    • 遠端患者監護 VS 遠程醫療
    • 目前監控系統:系統評估
    • 遠端患者監護:架構
    • 遠程監控系統的優點與課題
  • 產品的發表/認證
  • 產業的最新趨勢
  • 主要的國際企業
  • 全球市場的展望

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 其他亞太地區
  • 南美
    • 巴西
    • 其他南美國家
  • 其他地區

第4章 競爭情形

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7076

Abstract:

Global Remote Patient Monitoring Systems Market to Reach $1.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Remote Patient Monitoring Systems estimated at US$745.7 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at aCAGR of 12.9% over the period 2020-2027. Vital Sign Monitors, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$524.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Special Monitors segment is readjusted to a revised 12.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $220.4 Million, While China is Forecast to Grow at 12.4% CAGR

The Remote Patient Monitoring Systems market in the U.S. is estimated at US$220.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$302.8 Million by the year 2027 trailing a CAGR of 12.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 10.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Select Competitors (Total 83 Featured) -

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Vital Sign Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Special Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Sleep Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Hospital based Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Ambulatory Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 34: USA Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 43: Canada Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Canada 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 52: Japan Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 58: Japan Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Japan Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Japan 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 61: China Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 64: China Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 67: China Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: China Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: China 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 70: Europe Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Europe 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 82: France Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 85: France Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 88: France Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: France Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: France 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 91: Germany Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 94: Germany Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 97: Germany Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Germany Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Germany 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 100: Italy Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 103: Italy Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 106: Italy Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Italy Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Italy 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 109: UK Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 112: UK Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 115: UK Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: UK Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: UK 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 118: Rest of Europe Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Rest of Europe 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 121: Rest of Europe Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Rest of Europe 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 124: Rest of Europe Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Rest of Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Rest of Europe 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 127: Asia-Pacific Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Asia-Pacific 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 130: Asia-Pacific Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Asia-Pacific 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 133: Asia-Pacific Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Asia-Pacific 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 136: Rest of World Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of World Historic Review for Remote Patient Monitoring Systems by Product Type - Vital Sign Monitors and Special Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of World 15-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Vital Sign Monitors and Special Monitors for the Years 2012, 2020 & 2027
    • TABLE 139: Rest of World Current & Future Analysis for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of World Historic Review for Remote Patient Monitoring Systems by Application - Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of World 15-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 142: Rest of World Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Rest of World Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Rest of World 15-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 83